Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 101–200 of 1,016
Corticosteroids as adjunctive therapy in the treatment of influenza
Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub2 · Cited by 264
Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome
Busillo, J. M., Azzam, K. M., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275370 · Cited by 264
Self-citationThe immunobiology of MIF: function, genetics and prospects for precision medicine
Kang, I., & Bucala, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0238-2 · Cited by 267
Activation and Regulation of Systemic Inflammation in ARDS
Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E., & Sinclair, S. E. (2009) · Chest · doi:10.1378/chest.08-2408 · Cited by 260
Flaster, H., Bernhagen, J., Calandra, T., & Bucala, R. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0065 · Cited by 260
Meyer, U., Schwarz, M. J., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 258
“With regards to the latter, glucocorticoids havepotent anti-inflammatory properties by suppressing the production and/or secretion of proinflammatory molecules such as pro-inflammatory cytokines, prostaglandins, leukotrienes and COX-1/COX-2 (Rhen & Cidlowski, 2005).”
BackgroundSalvi, M., Vannucchi, G., Campi, I., Currò, N., Dazzi, D., Simonetta, S., Bonara, P., Rossi, S., Sina, C., Guastella, C., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02325 · Cited by 264
“Although our study is preliminary, since we have treated a relatively small number of patients, we suggest that while steroids may act more as anti-inflammatory agents (11, 32 ), RTX may affect TAO as a true immunosuppressor.”
ResultGlucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248
Self-citationOverview of Infections in the Immunocompromised Host
Dropulic, L. K., & Lederman, H. M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0026-2016 · Cited by 233
Mechanisms of Action of Topical Corticosteroids in Psoriasis
Uva, L., Miguel, D., Pinheiro, C., Antunes, J., Cruz, D., Ferreira, J., & Filipe, P. (2012) · International Journal of Endocrinology · doi:10.1155/2012/561018 · Cited by 241
“The inactivation of MAPKs and also of MAPKinteracting kinase by MKP-1 is due to the inhibition of PLA2 activity mediated by glucocorticoids [32].”
BackgroundInfluentialSingh, A. K., Majumdar, S., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.054 · Cited by 252
Acharya, N., Madi, A., Zhang, H., Klapholz, M., Escobar, G., Dulberg, S., Christian, E., Ferreira, M., Dixon, K. O., Fell, G., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.005 · Cited by 247
“In line with observations in acutely activated cells (Barrat et al., 2002; Bianchi et al., 2000; Brattsand and Linden, 1996; Rhen and Cidlowski, 2005), we found that repeated activation in the presence of GC profoundly suppressed the production of the pro-inflammatory cytokines IL-2, TNF- α, and IFN-γ, and induced the…”
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00843-z · Cited by 255
“Corticosteroids exert anti-inflammatory activities via genomic and nongenomic effects [61, 85].”
BackgroundGlucocorticoid use and abuse in SLE
Ruiz-Irastorza, G., Danza, A., & Khamashta, M. (2012) · Rheumatology · doi:10.1093/rheumatology/ker410 · Cited by 248
Corticosteroid-related central nervous system side effects
Ciriaco, M., Ventrice, P., Russo, G., Scicchitano, M., Mazzitello, G., Scicchitano, F., & Russo, E. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.120975 · Cited by 244
“The drug-receptor complex can trigger the transcription of anti-inflammatory genes such as NF-kB, AP-1, STAT, NFTA, c-Jun, Fos, and inhibit the production of cytokines and pro-inflammatory proteins such as chemotactic proteins and adhesion molecules.[7-9]”
Kim, M. S., An, M. H., Kim, W. J., & Hwang, T.-H. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003501 · Cited by 246
Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K., & Muglia, L. J. (2007) · Blood · doi:10.1182/blood-2006-10-048215 · Cited by 249
Strategies to improve drug development for sepsis
Fink, M. P., & Warren, H. S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4368 · Cited by 242
Gustafson, M. P., Lin, Y., New, K. C., Bulur, P. A., O'Neill, B. P., Gastineau, D. A., & Dietz, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq001 · Cited by 239
“4 patients with severe autoimmune disease [12-16].”
Basic and Clinical Pharmacology of Glucocorticosteroids
Becker, D. E. (2013) · Anesthesia Progress · doi:10.2344/0003-3006-60.1.25 · Cited by 233
“Any number of cellular functions are thereby modified, including the production of enzymes that regulate myriad metabolic processes and those that regulate synthesis of inflammatory autacoids and immune-related cytokines.(2,3,5) This mechanism is time consuming and accounts for a delayed onset of effect (6–8 hours) wh…”
BackgroundAdverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects
Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Ronald de Kloet, E., Fardet, L., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13091264 · Cited by 230
Self-citationAlijotas-Reig, J., Esteve-Valverde, E., Belizna, C., Selva-O'Callaghan, A., Pardos-Gea, J., Quintana, A., Mekinian, A., Anunciacion-Llunell, A., & Miró-Mur, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102569 · Cited by 235
“, NF-kβ and activator protein 1, and c/ glucocorticoid receptor–mediated effects on secondmessenger cascades [83].”
Epithelial cells and airway diseases
Proud, D., & Leigh, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01033.x · Cited by 229
Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
Baehr, L. M., Furlow, J. D., & Bodine, S. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.212845 · Cited by 234
“Synthetic glucocorticoids are widely used to treat inflammation (Rhen & Cidlowski, 2005) and muscular dystrophy (Matthews et al. 2010); however, they induce serious side effects such as muscle and bone loss (Decramer et al. 1994; Barry & Gallagher, 2003) and insulin resistance (Stojanovska et al.…”
BackgroundWiseman, A. C. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08570814 · Cited by 230
“Effects on the immune system are also numerous but most clearly related to inhibition of all cytokine transcription by blocking transcription factors, such as NF-kb and activator protein-1 (56).”
BackgroundZeng, C., Lane, N. E., Hunter, D. J., Wei, J., Choi, H. K., McAlindon, T. E., Li, H., Lu, N., Lei, G., & Zhang, Y. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.01.007 · Cited by 228
Pelly, V. S., Moeini, A., Roelofsen, L. M., Bonavita, E., Bell, C. R., Hutton, C., Blanco-Gomez, A., Banyard, A., Bromley, C. P., Flanagan, E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1815 · Cited by 225
“One way by which corticosteroids exert their anti-inflammatory effects is through inhibition of the COX2/PGE2 pathway (13).”
BackgroundGrøntved, L., John, S., Baek, S., Liu, Y., Buckley, J. R., Vinson, C., Aguilera, G., & Hager, G. L. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.106 · Cited by 229
“Glucocorticoids (GCs) are useful therapeutic tools for the management of auto-inflammatory diseases and for inhibiting cell growth of various cancers (Rhen and Cidlowski, 2005).”
Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224
“Thus, there is a critical need for orally active, brain-penetrant, small molecule therapeutics that can suppress excessive proinflammatory cytokine production by glia back towards homeostasis without being pan-suppressors, such as steroids with their untoward side effects and poor ability to alter pathophysiology prog…”
Pufall, M. A. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2895-8_14 · Cited by 218
Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
Sundahl, N., Bridelance, J., Libert, C., De Bosscher, K., & Beck, I. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.001 · Cited by 216
“These GRs are members of the steroid hormone receptor family of proteins (Rhen & Cidlowski, 2005; Kino et al., 2011).”
BackgroundCorticosteroids for treating sepsis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub3 · Cited by 210
HO, G. ‐., CHIAM, P., DRUMMOND, H., LOANE, J., ARNOTT, I. D. R., & SATSANGI, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02974.x · Cited by 218
VAN ZAANE, B., NUR, E., SQUIZZATO, A., GERDES, V. E. A., BÜLLER, H. R., DEKKERS, O. M., & BRANDJES, D. P. M. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04034.x · Cited by 210
Czarnetzki, C. (2008) · JAMA · doi:10.1001/jama.2008.794 · Cited by 217
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63432-0.00003-7 · Cited by 202
Galliher‐Beckley, A. J., & Cidlowski, J. A. (2009) · IUBMB Life · doi:10.1002/iub.245 · Cited by 206
“used to treat diseases such as inflammatory disorders, autoimmune diseases, and cancers (5).”
BackgroundSelf-citationMahata, B., Zhang, X., Kolodziejczyk, A. A., Proserpio, V., Haim-Vilmovsky, L., Taylor, A. E., Hebenstreit, D., Dingler, F. A., Moignard, V., Göttgens, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.011 · Cited by 212
“The immunoregulatory role of steroids has been extensively studied (Rhen and Cidlowski, 2005; Sakiani et al., 2013).”
Systemic corticosteroids for the treatment of COVID-19
Wagner, C., Griesel, M., Mikolajewska, A., Mueller, A., Nothacker, M., Kley, K., Metzendorf, M.-I., Fischer, A.-L., Kopp, M., Stegemann, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014963 · Cited by 208
Petta, I., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J., De Bosscher, K., & Libert, C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-15 · Cited by 203
“GR decreases the activity of NF- B and AP-1 by interacting with p38 (1) and JNK (2), respectively.”
BackgroundInfluentialKim, R. Y., Horvat, J. C., Pinkerton, J. W., Starkey, M. R., Essilfie, A. T., Mayall, J. R., Nair, P. M., Hansbro, N. G., Jones, B., Haw, T. J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.038 · Cited by 210
“Corticosteroids are broad-acting anti-inflammatory agents and the mainstay treatments for asthma.(1) However, 5% to 10% of asthmatic patients do not respond to steroid treatment.”
Ayroldi, E., Cannarile, L., Migliorati, G., Nocentini, G., Delfino, D. V., & Riccardi, C. (2012) · The FASEB Journal · doi:10.1096/fj.12-216382 · Cited by 194
“Many genes activated during the inflammatory process are repressed by GCs, and the multiplicity of the signals involved explains the complexity and magnitude of the pharmacological effects of GCs (3).”
BackgroundDexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
Noreen, S., Maqbool, I., & Madni, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173854 · Cited by 195
Rückerl, D., Jenkins, S. J., Laqtom, N. N., Gallagher, I. J., Sutherland, T. E., Duncan, S., Buck, A. H., & Allen, J. E. (2012) · Blood · doi:10.1182/blood-2012-02-408252 · Cited by 202
Löwenberg, M., Stahn, C., Hommes, D. W., & Buttgereit, F. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.002 · Cited by 201
Modulating Th2 Cell Immunity for the Treatment of Asthma
León, B., & Ballesteros-Tato, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637948 · Cited by 193
“can indirectly induce gene repression by GR interaction with DNA-bound transcription factors such as NF-κB and activator protein-1 (AP-1), resulting in the repression of the respective inflammatory signaling cascades (39, 45, 46).”
BackgroundSteroids: pharmacology, complications, and practice delivery issues.
Ericson-Neilsen, W., & Kaye, A. D. (2014) · PubMed · Cited by 306
Antitussive Drugs—Past, Present, and Future
Dicpinigaitis, P. V., Morice, A. H., Birring, S. S., McGarvey, L., Smith, J. A., Canning, B. J., & Page, C. P. (2014) · Pharmacological Reviews · doi:10.1124/pr.111.005116 · Cited by 194
“However, there is very little published clinical data to suggest clinical efficacy with carbetapentane leading the FDA (2007) to conclude that this drug should not be made available as an OTC treatment of cough in the USA (2007).”
BackgroundAcute severe ulcerative colitis: from pathophysiology to clinical management
Hindryckx, P., Jairath, V., & D'Haens, G. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.116 · Cited by 192
Panoulas, V. F., Douglas, K. M. J., Stavropoulos-Kalinoglou, A., Metsios, G. S., Nightingale, P., Kita, M. D., Elisaf, M. S., & Kitas, G. D. (2008) · Rheumatology · doi:10.1093/rheumatology/kem311 · Cited by 193
“mineralocorticoid receptors by cortisol in the setting of reduced 11� -hydroxysteroid dehydrogonase-2 activity [33] or GC excess, and prostaglandin production inhibition [ 34 ] are some of the suggested mechanisms in the literature.”
BackgroundBai, R., Yao, C., Zhong, Z., Ge, J., Bai, Z., Ye, X., Xie, T., & Xie, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113165 · Cited by 181
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Shini, S., Huff, G. R., Shini, A., & Kaiser, P. (2010) · Poultry Science · doi:10.3382/ps.2009-00483 · Cited by 189
“Glucocorticoids have beneficial effects against bacterial disease in which the major pathology involved local or generalized inflammation (Rhen and Cidlowski, 2005).”
BackgroundPrimary Sjögren’s syndrome and the eye
Bjordal, O., Norheim, K. B., Rødahl, E., Jonsson, R., & Omdal, R. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2019.10.004 · Cited by 183
Implications of immune dysfunction on endometriosis associated infertility
Miller, J. E., Ahn, S. H., Monsanto, S. P., Khalaj, K., Koti, M., & Tayade, C. (2017) · Oncotarget · doi:10.18632/oncotarget.12577 · Cited by 186
“Dexamethasone is a glucocorticoid that has been shown to reduce the expression of prostaglandins and other inflammatory mediators dysregulated in endometriosis [78].”
BackgroundPeptide-based supramolecular hydrogels for local drug delivery
Zhang, Z., Ai, S., Yang, Z., & Li, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.010 · Cited by 191
Cortisol synthesis in epidermis is induced by IL-1 and tissue injury
Vukelic, S., Stojadinovic, O., Pastar, I., Rabach, M., Krzyzanowska, A., Lebrun, E., Davis, S. C., Resnik, S., Brem, H., & Tomic-Canic, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188268 · Cited by 193
Dry eye: an inflammatory ocular disease.
Hessen, M., & Akpek, E. K. (2014) · PubMed Central · Cited by 246
O’Neill, A., & Lirk, P. (2022) · Anesthesiology Clinics · doi:10.1016/j.anclin.2022.04.002 · Cited by 171
Tissue-specific glucocorticoid action: a family affair
Gross, K. L., & Cidlowski, J. A. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.07.009 · Cited by 180
“accepted that the anti-inflammatory properties of glucocorticoids involve trans repression and are caused by interference with AP-1- and NFκB-mediated gene transcription [2,34].”
BackgroundSelf-citationWon, E., & Kim, Y.-K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186546 · Cited by 178
“Glucocorticoid receptor binding also exerts anti-inflammatory effects by inhibiting nuclear factor kappa B [18].”
Backgroundvan Zuiden, M., Geuze, E., Willemen, H. L. D. M., Vermetten, E., Maas, M., Heijnen, C. J., & Kavelaars, A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050706 · Cited by 190
Marcus, H. J., Carpenter, K. L. H., Price, S. J., & Hutchinson, P. J. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9990-5 · Cited by 186
“Dexamethasone’s actions are complex, wide-ranging and incompletely understood [ 54 , 55].”
BackgroundWang, Y., Jiang, W., He, Q., Wang, C., Liu, B., Zhou, P., Dong, N., & Tong, Q. (2020) · medRxiv · doi:10.1101/2020.03.06.20032342 · Cited by 184
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.017 · Cited by 181
“mines [52] and recent studies have shown that corticosterone enhances phenylephrine-induced contraction of intact aortic rings”
MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
Li, L., Zhang, J., Diao, W., Wang, D., Wei, Y., Zhang, C.-Y., & Zen, K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301309 · Cited by 179
“It is generally believed that Dex executes its effects by upregulating the expression of anti-inflammatory proteins or downregulating the expression of proinflammatory proteins (37).”
BackgroundCooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Circadian endocrine rhythms: the hypothalamic–pituitary–adrenal axis and its actions
Nicolaides, N. C., Charmandari, E., Chrousos, G. P., & Kino, T. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12464 · Cited by 183
Lloyd, E., Somera-Molina, K., Van Eldik, L. J., Watterson, D. M., & Wainwright, M. S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-28 · Cited by 180
“However, steroids used as drugs are well known for their diverse and sometimes divergent outcomes that can vary with the type of injury as well as drug dosing [59,60].”
BackgroundFriedler, B., Crapser, J., & McCullough, L. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1377-9 · Cited by 174
“, NF-κB) while simultaneously transactivating anti-inflammatory gene expression [87, 103].”
BackgroundCOX-2 in Inflammation and Resolution
Rajakariar, R. (2006) · Molecular Interventions · doi:10.1124/mi.6.4.6 · Cited by 178
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
“Named for their effect on carbohydrate metabolism, glucocorticoids (GCs) regulate different cellular functions as homeostasis, metabolism, development, cognition, and inflammation [1].”
BackgroundFarah, S., Doloff, J. C., Müller, P., Sadraei, A., Han, H. J., Olafson, K., Vyas, K., Tam, H. H., Hollister-Lock, J., Kowalski, P. S., et al. (2019) · Nature Materials · doi:10.1038/s41563-019-0377-5 · Cited by 181
Fontana, L., Villareal, D. T., Das, S. K., Smith, S. R., Meydani, S. N., Pittas, A. G., Klein, S., Bhapkar, M., Rochon, J., Ravussin, E., et al. (2016) · Aging Cell · doi:10.1111/acel.12400 · Cited by 168
“Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.”
BackgroundDuma, D., Collins, J. B., Chou, J. W., & Cidlowski, J. A. (2010) · Science Signaling · doi:10.1126/scisignal.2001077 · Cited by 178
“Synthetic glucocorticoids are a mainstay in the treatment of many inflammatory and autoimmune diseases (10), for which they are prescribed largely without consideration for patient gender.”
BackgroundSelf-citationMolecular mechanisms regulating glucocorticoid sensitivity and resistance
Gross, K. L., Lu, N. Z., & Cidlowski, J. A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.001 · Cited by 180
Self-citationGlucocorticoid receptor signalling activates YAP in breast cancer
Sorrentino, G., Ruggeri, N., Zannini, A., Ingallina, E., Bertolio, R., Marotta, C., Neri, C., Cappuzzello, E., Forcato, M., Rosato, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14073 · Cited by 176
Corticosteroids for treating sepsis in children and adults
Annane, D., Bellissant, É., Bollaert, P. E., Briegel, J., Keh, D., Kupfer, Y. Y., Pirracchio, R., & Rochwerg, B. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub4 · Cited by 200
Chu, C.-C., Hsing, C.-H., Shieh, J.-P., Chien, C.-C., Ho, C.-M., & Wang, J.-J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.008 · Cited by 165
New insights into the cell- and tissue-specificity of glucocorticoid actions
Quatrini, L., & Ugolini, S. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00526-2 · Cited by 164
Bosma-den Boer, M. M., van Wetten, M.-L., & Pruimboom, L. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-32 · Cited by 164
“T-cell apoptosis ↑ Negative: cytokines, T-cell activity ↓, LT ↓: switch from phase 1 to 2 ↓ or no switch DMARDs: Sulphasalazine (SSZ) [86] SSZ: strong and potent inhibitor of NFkB-activation5-amino acytelate (5- ASA): PG ↓sulpha-pyridine Less NFkB activation ↓: IL-2 of activated T-cells ↓, TNF alfa & IL-1 macro-phages…”
BackgroundInfluentialHarrison, M., & Langley-Evans, S. C. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508057607 · Cited by 169
Interactions between Temperament, Stress, and Immune Function in Cattle
Sanchez, N. C. B., Randel, R. D., Carroll, J. A., & Welsh, T. H. (2011) · International Journal of Zoology · doi:10.1155/2011/373197 · Cited by 210
“Approximately 1–10% of cortisol circulates as a “free” steroid [31, 32].”
BackgroundEndocrine Effects of Circadian Disruption
Bedrosian, T. A., Fonken, L. K., & Nelson, R. J. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105102 · Cited by 170
“Diurnal rhythms in melatonin and glucocorticoids can directly affect immune responses through their potent anti-inflammatory actions (110, 111).”
BackgroundCorticosteroids in Acute Lung Injury: The Dilemma Continues
Mokra, D., Mikolka, P., Kosutova, P., & Mokry, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194765 · Cited by 166
“) and regulator proteins important for metabolism, whereas this process (“transactivation”) is likely responsible also for numerous adverse effects [38,39].”
BackgroundFini, M. E., Schwartz, S. G., Gao, X., Jeong, S., Patel, N., Itakura, T., Price, M. O., Price, F. W., Varma, R., & Stamer, W. D. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.09.003 · Cited by 163
Lucassen, P. J., Oomen, C. A., Naninck, E. F. G., Fitzsimons, C. P., van Dam, A.-M., Czeh, B., & Korosi, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021303 · Cited by 166
Regulation of cortisol bioavailability—effects on hormone measurement and action
Perogamvros, I., Ray, D. W., & Trainer, P. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.134 · Cited by 158
Glucocorticoids and endothelial cell barrier function
Salvador, E., Shityakov, S., & Förster, C. Y. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1762-z · Cited by 174
“Glucocorticoids (GCs) belong to a class of steroid hormones that bind to GC receptors (GRs), which, once activated as a complex, upregulate the expression of anti-inflammatory proteins in the nucleus and repress the expression of proinflammatory proteins in the cytosol (Rhen and Cidlowski 2005).”
BackgroundInfluentialGlucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
Qi, D., & Rodrigues, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2006 · Cited by 162
“This unique action will limit the sensitivity of glucocorticoids (141).”
BackgroundLöwenberg, M., Verhaar, A. P., Bilderbeek, J., van Marle, J., Buttgereit, F., Peppelenbosch, M. P., van Deventer, S. J., & Hommes, D. W. (2006) · EMBO reports · doi:10.1038/sj.embor.7400775 · Cited by 157
“GCs also evoke nongenomic effects on cellular function, which occur in minutes (Baus et al, 1996; Croxtall et al, 2000; Rhen & Cidlowski, 2005).”
BackgroundLRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease
Coste, A., Dubuquoy, L., Barnouin, R., Annicotte, J.-S., Magnier, B., Notti, M., Corazza, N., Antal, M. C., Metzger, D., Desreumaux, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702440104 · Cited by 160
Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor
Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-07 · Cited by 160
“Glucocorticoids are widely used in the clinic to treat a variety of diseases including inflammation, cancer, and autoimmune disorders (23).”
BackgroundSelf-citationGlucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Löwenberg, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.001 · Cited by 189
Glucocorticoid Dysregulations and Their Clinical Correlates: From Receptors to Therapeutics
Marques, A. H., Silverman, M. N., & Sternberg, E. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04987.x · Cited by 158
Quispe-Laime, A. M., Bracco, J. D., Barberio, P. A., Campagne, C. G., Rolfo, V. E., Umberger, R. A., & Meduri, G. U. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1727-6 · Cited by 165
“There has been significant advancement in our understanding of the cellular mechanisms of corticosteroid action [12] and the interaction between corticosteroids and transcription factors for inflammatory cytokines in critical illness and ARDS [13, 14].”
BackgroundChronopharmacology of glucocorticoids
Scherholz, M. L., Schlesinger, N., & Androulakis, I. P. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.004 · Cited by 144
“Generally, low levels of glucocorticoids are associated with more severe inflammatory responses due to rising levels of proinflammatory mediators, whereas high levels of glucocorticoids, particularly in the absence of inflammation, leads to increased risk of infections and issues with immunity due to the immunosuppres…”
BackgroundSocial regulation of leukocyte homeostasis: the role of glucocorticoid sensitivity
Cole, S. W. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.02.006 · Cited by 156
“The fact that the HPA axis has evolved to serve as both a primary regulator of endogenous inflammation (Munck and Guyre, 1986; Ruzek et al., 1999; Rhen and Cidlowski, 2005; Onard et al., 2007) and a primary regulator of physiologic responses to social threat (Dickerson and Kemeny, 2004) implies…”
InfluentialExtra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Quatrini, L., Wieduwild, É., Escalière, B., Filtjens, J., Chasson, L., Laprie, C., Vivier, É., & Ugolini, S. (2018) · Nature Immunology · doi:10.1038/s41590-018-0185-0 · Cited by 161
“Finally, glucocorticoids are clinically effective against many inflammatory and autoimmune diseases 13.”
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.